The Movement Disorder Society

Abstract Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


A 3D gyroscope better suited than a 3D accelerometer for measuring tremor
Pallavaram S., Phibbs F., Hedera P., Tolleson C., Rodriguez W., D'Haese P.F., Dawant B.M., Davis T.L.

A 6-week, double-blind, multicenter RCT in Parkinson's disease patients to explore the efficacy and safety of AFQ056 when combined with increased doses of L-dopa
Kumar R., Hauser R.A., Mostillo J., Dronamraju N., Graf A., Merschhemke M.

A biomaterials approach to modulate striatal toxicity of gene vectors: A comparative study
Newland B., Moloney T., Mulcahy P., Dowd E., Pandit A.

A case of adult onset Sandifer syndrome
Yousuf S., Rana M.A., Rana A.Q.

A case of amiodarone-induced myoclonus responsive to levetiracetam
Deik A.F., Shanker V.L.

A case of familial amyloid polyneuropathy with parkinsonism
Taneja S.R., Tse W.

A case of hemichorea-hemiballismus with prominent dystonia treated with tetrabenazine and chemodenervation
Umeh C.C., Nichols P., Rosenthal L.S., Mari Z.

A case of sporadic, generalized, late onset paroxysmal kinesigenic dyskinesia
Luca C.C., Roque D.A., Singer C.

A case of treatment-resistant symptomatic headache induced by deep brain stimulation (DBS) of the internal globus pallidus (GPi)
Krause P., Gaul C., Totzeck A., Bruecke C., Huebl J., Gruber D., Kupsch A., Schneider G.H., Kuehn A.A.

A classification algorithm for camptocormia in Parkinson's disease patients
Mukai Y., Furusawa Y., Kawazoe T., Sato H., Sano T., Sakamoto T., Murata M.

A clinicopathological study of parkin-linked parkinsonism A study of 5 cases and comparison with Parkinson's disease
Doherty K.M, Silveira-Moriyama L., Parkkinen L., Healy D., Farrell M., Mencacci N.E., Ahmed Z., Brett F., Hardy J., Quinn N., Counihan T.T., Lynch T., Revesz T., Lees A.J., Holton J.L.

A comparative study of idiopathic and secondary restless legs syndrome in pregnancy
Miri S., Vahdat M., Sariri E., Rohani M., Sabet A.

A comparative study on safety and tolerability of rasagiline versus pramipexole in early Parkinson's disease (PD): The ACTOR study
Viallet F., Pitel S., Lancrenon S., Blin O.

A comparative transversal cross-sectional study of cancer prevalence in parkinsonian and non-parkinsonian population in our area
Ybot-Gorrin I., Vivancos-Matellano F., Tallon-Barranco A., Diez-Tejedor E.

A comparison of adverse events with monoamine oxidase inhibitors and catechol-o-methyl transferase inhibitors in combination with levodopa for patients with Parkinson's disease
Zhang R., Hohler A.D., Saint-Hilaire M.

A comparison of rapid finger tapping and finger flexion-extension tasks in Parkinson's disease
Teo W.P., Rodrigues J.P., Mastaglia F.L., Thickbroom G.W.

A comparison of the diagnosis and treatment processes of families with myoclonic dystonia in the UK and the US
McPherson K.B., Butler A.G.

A comparison of voluntary and forced exercise in driving neuroprotection in a hemiparkinsonian rat model
Landers M.R., Kinney J.W., Elekonich M.M., Allen D.N., van Breukelen F.

A de novo case of tourettism caused by citalopram in an adult patient
Ferreira M.A., Galvez N.

A double blind, randomized, multicenter, crossover study to demonstrate the non-inferiority of abobotulinumtoxinA in the clinical efficacy and safety in comparison with botulinum toxin a, assuming a bioequivalence ratio of 2.5:1 units, in the treatment of cervical dystonia
Ehm G., Yun J.Y., Jeon B.S., Kim H.J.

A double-blind, randomized, controlled, crossover trial of bilateral deep brain stimulation to the globus pallidus internus in severe Tourette syndrome
Kefalopoulou Z., Zrinzo L., Beigi M., Hariz M., Jahanshahi M., Limousin P., Joyce E., Foltynie T.

A functional mechanism for deep brain stimulation in Parkinson's disease: The slow axon blockade hypothesis
Garcia M.R., Pearlmutter B.A., Wellstead P.E., Verwoerd M., Middleton R.H.

A genetic study of Wilson's disease in the United Kingdom
Bandmann O., Coffey A., Durkie M., Rattray M., Dalton A.

A kinematic and electromyography functional assessment of balance in Parkinson's disease Pilot study
Capato T., Barbosa E.R., Piemonte M.E.

A meta-analysis on the effect of topiramate in essential tremor
Penaserada L.A., Diesta C.C.E.

A multicenter Italian sleep study: Hypertension in peri and post menopausal women is strongly related to sleep quality, RLS and mood alteration
Arico I., Vita G., Condurso R., Bonanni E., Fabbrini M., Tramonti F., Bonsignore M.R., Zito A., Russo G., Pagliarulo M.G., Guarneri B., Cerroni G., Mennuni G.F., Della Marca G., Silvestri R.

A multicenter, open-label study to assess the long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension (NOH 304)
Shill H., Vernino S., Hutchman R., Adkins L., Isaacson S.

A multicentre European comparative survey of motor and non motor effects of subcutaneous apomorphine infusion and intrajejunal levodopa infusion in Parkinson's disease
Reddy P., Martinez-Martin P., Antonini A., Calandrella D., Pilleri M., Odin P., Martin A., Henriksen T., Rizos A., Katzenschlager R., Bryndum N., Glad A., Timmermann L., Salimi Dafsari H., Ebersbach G., Kramberger M.G., Trost M., Pirtosek Z., Wenzel K., Tomantschger V., Storch A., Reichmann H., Ceballos-Baumann A., Chaudhuri K.R.

A new mutant mouse with symptoms of dystonia
Sweadner K.J., Liu Y.B., Ozelius L.J., Brashear A.

A new mutation in anoctamin 10 gene associated with isolated autosomal recessive cerebellar ataxia
Marcel C., Kamsteeg E.J., Scheffer H., Koenig M., Tranchant C.

A new SETX mutation together with previously described SETX mutation causing AOA2 in two sibling patients
Datta N., Hohler A.

A new tool for assessment and balance training of patients with Parkinson's disease based on low cost comercial Wii balance board
dos Santos A., Pegollo F., Alencar R., Avanzi R., Pompeu J.E.

A novel genetic prediction score in myoclonus-dystonia
Carecchio M., Magliozzi M., Copetti M., Ferraris A., Bernardini L., Bonetti M., Edwards M.J., Torrente I., Pellegrini F., Comi C., Bhatia K.P., Valente E.M.

A novel NKX2A-mutation causing benign hereditary chorea is associated with non-progressive striatal D2-receptor dysfunction
Haubenberger D., Bauer P., Lieba-Samal D., Zimprich A., Auff E., Pirker W.

A novel pattern of FDG-PET regional metabolic defect in focal arm dystonia
Marousi S., Tagaris G.A., Karageorgiou C.E.

A novel sign to differentiate neuroacanthocytosis from other causes of oro-lingual dyskinesias: Case series
Awadh M.M.M.

A novel test for assessing gait under multiple-task conditions: Comparison of the performance among adults, elderly and patients with Parkinson's disease
Tardeli E., Santo N., Bovi R., Bertolo D., Piemonte M.E.P.

A novel TOR1A mutation in a patient with segmental dystonia
Graf J., Lohmann K., Ferbert A., Kostic V., Moro E., Munchau A., Kuhn A.A., Altenmuller E., Zeuner K., Hagenah J., Bruggemann N., Klein C., Schmidt A.

A palliative care service for Parkinson's disease: Patient characteristics and service interventions
Richfield E., Adams D., Jones E., Johnson M., Campbell C.

A phase II, double-blind, randomized, placebo-controlled 4-way crossover study to evaluate the relative efficacy and safety of OC oral solution (oxybutynin and clonidine) for sialorrhoea in patients with Parkinson's disease
Chnag C.T., Chen P.

A phase III clinical trial of coenzyme Q10 (QE3) in early Parkinson's disease: Parkinson Study Group QE3 Investigators
Beal M.F.

A placebo-controlled, randomized, multicenter study of rasagiline as add-on therapy to dopamine agonists for the treatment of early Parkinson's disease: The ANDANTE study
Hauser R.A., Choudhry A.

A potential role for mRNA surveillance in Parkinson's disease?
Henderson A., Chow D., Yin H., Beach T.G., Dunckley T.

A proposal for a physiotherapy programme to improve gait, balance and functional independence in Huntington's disease
Capato T., Haddad M., Piemonte M.E., Barbosa E.R.

A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: Early stopping for lack of efficacy
Tilley B.C., Mainous III A.G., Elm J.J., Pickelsimer E., Soderstrom L.H., Ford M.E., Diaz V.A., Siminoff L.A., Burau K., Smith D.W.

A randomized, double-blind, placebo-controlled clinical trial of rifampicin in multiple system atrophy
Gilman S., Low P.A., Robertson D., Bioggioni I., Freeman R., Kaufmann H., Perlman S., Hauser R.A., Cheshire W.P., Lessig S.L., Vernino S.

A randomized, double-blind, placebo-controlled study comparing the efficacy, safety and tolerability of levodopa-carbidopa (tidomet) versus placebo in patients with X-linked dystonia-parkinsonism (XDP)
Jamora R.D.G., Pasco P.M.D., Teleg R.A., Villareal-Jordan R.F., Borres R., Tolentino C., Monding M.J.H., Sarcia S., Lee L.V.

A randomized, placebo-controlled clinical trial to assess the effects of rasagiline in patients with multiple system atrophy of the parkinsonian subtype
Poewe W., Barone P., Gliadi N., Gilman S., Low P.A., Sampaio C., Seppi K., Wenning G.K., For the Rasagiline-for-MSA Investigators 

A rare variant near a potassium channel-related gene in familial restless legs syndrome
Pichler I., Schwienbacher C., Zanon A., Fuchsberger C., Serafin A., Marroni F., Facheris M.F., Tellgren-Roth C., Gyllensten U., Gusella J.F., Hicks A.A., Pramstaller P.P.

A rat knockin model of early onset DYT1 generalized dystonia displays abnormal hindlimb gait
Frenz C.T., Singh M., Shashidharan P.

A review of the preclinical literature for the potent and selective A2A receptor antagonist preladenant
Hodgson R.A., Parker E.M.

A rodent model for direct visualization of -synuclein oligomers in the nigrostriatal system
Kalia L.V., Dimant H., Kalia S.K., Kibuuka L.N., Ebrahimi-Fakhari D., McFarland N.R., McLean P.J.

A substantial investigation on psychiatric symptoms in patients with Parkinson's disease-(PD) from our own out-patients survey
Hasegawa K., Yokoyama T., Horiuchi E., Kaneko E., Kumon A., Kawashima N.

A survey of tardive dyskinesia among institutionalised Nigerian patients with schizophrenia
Adelufosi A.O., Fadipe B.

A survey of the identification and management of depression in people with Parkinson's disease
Simpson A.C., Samuel M., Brown R.G.

A survey of the management of psychosis in Parkinson's disease
Lonnen J., McNeil L., Capek E., McCarthy C., McGill V., MacPhee G., Stewart D.

A systematic review of the occurrence of psychotic features in people with Parkinson's disease
Caslake R., Emeka A., Counsell C.

A systematic review on the effectiveness of spasticity management using physical interventions in patients with stroke
Shukla R., Sim E., Tan D.

A transatlantic sibpair diagnosis of dopamine responsive dystonia (Segawa's disease) with leg atrophy and a new mutation
Mulroy E., Costelloe D., Stevenson M., Ross O., Lynch T.

A triangle of signs: Palatal myoclonus, dysarthria and progressive ataxia
O'Dowd S.T., Roberts K.A., Lynch T.

Abnormal 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy in two patients with spastic paraplegia 11 (SPG11)
Furuya H., Arahata H., Miura S., Watanabe A., Kawano Y., Araki E., Kumazoe H., Fujii N.

Abnormal processing of the nociceptive input in Parkinson's disease occurs in the central nervous system: Evidence from Nd-YAP laser evoked potentials
Zambito Marsala S., Morgante F., Fornasier A., Fabris F., Lo Cascio C., Marchini C., Defazio G., Tinazzi M.

Abnormalities in functional and structural brain networks are evident in Parkinson's disease with and without cognitive impairment
Hu C., Pool S., Visscher K., Walsh R.R.

Abnormalities of voice quality in progressive supranuclear palsy (PSP)
Skodda S., Gronheit W., Schlegel U.

Abnormalities of voice quality in the course of disease progression in Parkinson's disease
Gronheit W., Schlegel U., Skodda S.

Accelerometric study of the effect of limb cooling on tremor in essential tremor patients
Evidente V., Hentz J., Duffy A.

Accordion pill carbidopa/levodopa for improved treatment of advanced Parkinson's disease symptoms
LeWitt P.A., Friedman H., Giladi N., Gurevich T., Shabtai H., Djaldetti R., Roizen N., Hassin-Baer S., Cohen O., Yahalom G., Schlesinger I., Nassar M., Milo R., Navon N.

Accuracy of the NINDS-SPSP and the NNIPPS diagnostic criteria for the clinical diagnosis of progressive supranuclear palsy
Respondek G., Roeber S., Gaig C., Troakes C., Van Swieten J., Oertel W.H., Hoeglinger G.U.

Activated microglia in Parkinson's disease: A PET study with a novel radiotracer, 18FFEPPA
Koshimori Y., Ko J.H., Mizrahi R., Rusjan P.M., Wilson A.A., Houle S., Lang A.E., Strafella A.P.

Acupuncture-induced dopaminergic neuron protection and motor function improvement mediated by phosphatidylinositol 3-kinase/Akt signaling pathway in the mice with MPTP-induced Parkinson's disease model
Bae H., Kim S.N., Doo A.R., Park J.Y., Park H.J.

Acute catatonia during pregnancy secondary to anti NMDA-R encephalitis
Mc Carthy A., Dineen J., Lynch T., O'Rourke K.

Acute decompensation of Parkinson's disease
Datieva V.K.

Acute impedance changes of DBS system & corresponding stimulation estimates
Steinke G.K., Moffitt M.A., Carcieri S., Jackson A., Makous J., Stoffregen W., Wojick L.

Acute phenytoin-induced dyskinesia
Nunez Y., De la Cruz W., Rafael S., Cosentino C., Torres L.

Acute psychosis following insertion of deep brain stimulator in a patient with Parkinson's disease
Crotty G.F., Sweeney B., Cassidy E.

Adapting the Sniffin Sticks olfactory test to diagnose Parkinson's disease in Estonia
Antsov E., Kilk S., Silveira-Moriyama L., Kadastik-Eerme L., Toomsoo T., Paju T., Lees A., Taba P.

Addiction to levodopa: Dopamine dysregulation syndrome in Parkinson's disease
Pandey S., Mehndiratta M.

Adherence to once-daily dopamine agonists in levodopa-treated Parkinson's disease patients is related to first dopamine replacement therapy
Santos-Garcia D., Prieto-Formoso M., de la Fuente-Fernandez R.

Adult onset idiopathic focal lower extremity dystonia: A comparative phenomenological analysis of this novel task specific dystonia
Ramdhani R.A., Cho C., Frucht S.J.

Adult onset tic disorders A case series
Knight T.E., Pringsheim T.

Adult Tay-Sachs disease with extrapyramidal features associated with a novel mutation in the HEXA gene
Lefter S., O'Mahony O., Sweeney B., Ryan A.M.

Aerobic & balance training class and voice & communication group for community dwelling clients with Parkinson's disease
Kelly C., Durairaj S., Fenton Y., Sayers K.

Alien limb syndrome with dramatic response to risperidone treatment
Luca C.C., Velez-Aldahondo V., Nahab F.B.

Alpha-synuclein as a biomarker of Parkinson's disease: A systematic review
Malek N., Swallow D., Grosset K., Grosset D.

Alpha-synuclein H50Q, a novel pathogenic mutation for Parkinson's disease
Appel-Cresswell S., Vilarino-Guell C., Yu I., Shah B., Weir D., Thompson C., Stoessl J.A., Farrer M.J.

Altered fronto-striatal connectivity in Parkinson's disease (PD) using diffusion tensor imaging (DTI) tractography
Koshimori Y., Christopher L., Lang A.E., Houle S., Strafella A.P.

Amantadine: Adverse cutaneous side-effects, a prospective follow-up study
Herranz A., del Val J., Garcia-Ruiz P.J.

Ambulatory activity monitor in the evaluation of de novo Parkinson's disease patients
Garcia-Ruiz P.J., Lopez Manzanares L., Catalan M.J., Martinez-Castrillo J.C., Lopez Aristegui N., Velazquez J.M., Rojo A.

Ambulatory activity monitoring: Capturing participation-level decline in Parkinson's disease
Dibble L.E., Cavanaugh J.T., Earhart G., Ellis T., Ford M.P., Foreman K.B.

An adult-onset neurodegeneration with brain iron accumulation presented dystonia, dementia, epilepsy and peripheral neuropathy: A clinicopathological study
Matsumoto M., Kikkawa Y., Toma S., Arai K.

An audit of apomorphine in the management of complex idiopathic Parkinson's disease in Ireland
Magennis B., Cashell A., O'Brien D., Lynch T.

An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population
Picillo M., Amboni M., Moccia M., Erro R., Barone P.

An evaluation of an upper limb/handwriting group for people with Parkinson's disease
Cooper C., Stringer R.

An impairment of visuomotor skill flexibility in Parkinson's disease
Joundi R.A., Brittain J.S, Bogdanovic M., Aziz T.Z., Brown P., Jenkinson N.

An interdisciplinary model of care for Huntington's disease (HD) families
Rao A.K., Moskowitz C.B., Wasserman P.L., Marder K.S.

An international study to investigate rotigotine dose response (2-8 mg/24 h) on off time in patients with advanced stage Parkinson's disease
Elmer L.W., Chana P., Borgohain R., Surmann E., Bauer L., Whitesides J., Nicholas A.P.

An observational study of the impact of early versus delayed treatment on quality of life in Parkinson's disease
McGhee D.J.M., Caslake R., Harris C.E., Counsell C.E.

An open label, single site, 12 month, phase II, randomised controlled trial evaluating the safety and efficacy of Exendin-4 (Exenatide) in the treatment of patients with moderate severity Parkinson's disease
Aviles-Olmos I., Kefalopoulou Z., Djamshidian A., Limousin P., Dickson J., Lees A., Foltynie T.

An updated flow chart for the evaluation of chorea
Walker R.H.

Analysis of efficacy and safety outcomes in patients treated with droxidopa in combination with other drug classes
LeWitt P., Gorny S.

Analysis of efficacy in patients with symptomatic neurogenic orthostatic hypotension treated with droxidopa and dopa-decarboxylase inhibitors
Biaggioni I., Low P., Rowse G., Kaufmann H.

Analysis of GWAS-linked GAK locus in ethnic Chinese
Koh Y.H., Au W.L., Tan L.C., Prakash K.M., Tan E.K., Zhao Y.

Analysis of LINGO1 (rs9652490) polymorphism in essential tremor and sporadic Parkinson's disease in a Taiwanese population
Chen P.Y., Lu C.S., Yan S.H., Lai S.C., Chen R.S., Yeh T.H.

Analysis of mitochondrial DNA variations in Friedreich's ataxia (FRDA) patients in Indian families: Identification of disease associated markers
Singh I., Mohammed F., Srivastava A., Mukerji M.

Analysis of Parkinson's disease questionnaire data when missing is not at random
Luo S., Su X., He B., Tilley B.C.

Analysis of PITX3 gene in patients with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration
Jamrozik Z., Berdynski M., Zekanowski C., Baranczyk-Kuzma A., Slawek J., Kuzma-Kozakiewicz M.

Analysis of smell in Wilson's disease
Carvalho M.J., Machado A.A.C., Barbosa E.R.

Analysis of stereotactic accuracy in patients undergoing deep brain stimulation using Nexframe and Leksell frame
Bot M., van den Munckhof P., Bakay R.A.E, Sierens D., Stebbins G.T., Verhagen Metman L.

ANCHOR-CD (AbobotulinumtoxinA Neurotoxin: Clinical & Health economics Outcomes Registry in Cervical Dystonia): A multicenter, observational study of dysport in cervical dystonia: Baseline data and cycle one outcomes data
Trosch R.M., Comella C.L., Lew M.F., LeWitt P.A., Singer C., Russell S., Chang S., Clary C.M., Silay Y., Coleman C.M., Marchese D., Hubble J.P.

ANCHOR-CD (AbobotulinumtoxinA Neurotoxin: Clinical & Health economics Outcomes Registry in Cervical Dystonia): A multicenter, observational study of dysport in cervical dystonia: Patient demographic, history, and health economics data
Trosch R.M., Comella C.L., Lew M.F., LeWitt P.A., Singer C., Marchese D., Russell S., Chang S., Clary C.M., Silay Y., Coleman C.M., Hubble J.P.

Anticholinergic load: Is there a cognitive cost in early Parkinson's disease?
Yarnall A.J., Khoo T.K., Duncan G.W., Rochester L., Barker R.A., Brooks D.J., Burn D.J.

Anticholinergic responsive hemiparkinsonism due to coiled posterior cerebral artery aneurysm
Kumar H., Bhattacharjee S., Mallick S., Tiwari M.

Antidromic activation of cortex by clinically effective thalamic DBS for essential tremor
Walker H.C., Huang H., Gonzalez C., Bryant J.E., Cutter G.C., Montgomery Jr. E.B., Yildirim A., Guthrie B.L., Watts R.L.

Anti-glycine receptor antibody causing relapsing encephalitis with rigidity and myoclonus
Williams J., O'Connell K., O'Riordan S., McGuigan C., Connolly S., Vincent A., Hutchinson M.

Anti-parkinsonian effects of Nurr1 activator in UPS impairment induced animal model of Parkinson's disease
Zhang Z., Xie W., Hintermann S., Jankovic J., Le W.

Antiparkinsonian therapy and olfactory discrimination in hemiparkinsonian rats
Marin C., Bonastre M., Mullol J.

Antiphospholipid antibody-associated dystonia: A case report and literature review
Kurzweil A., Gilbert R.

Antisaccadic task deficits in spinocerebellar ataxia type 2: Insight into CAG repeats role on frontal-executive dysfunctions
Rodriguez-Labrada R., Velazquez-Perez L., Oberschmidt C., Canales-Ochoa N., Aguilera-Rodriguez R., Medrano-Montero J., Estupinan-Rodriguez A., Pena-Acosta A., Gonzalez-Zaldivar Y., Vazquez Mojena Y., Cruz Marino T., Auburger G.

Antisense oligonucleotides as molecular tools to silence prolonged (CAG)n tracts in Huntington's disease
Vlamings R., Evers M.M., van Roon-Mom W.M.C., Mulders S.A.M., Janssen M.L.F., Verheul R.C., van Deutekom J.C.T., Temel Y.

Anxiety symptoms among cognitively-intact, community dwelling Filipino patients with Parkinson's disease
Rosales R.L., Go C.L., Joya-Tanglao M., Ng A.R., de los Santos M.D.

Apathy and mania induced by subthalamic nucleus stimulation
Guven H., Kocer B., Comoglu S.S., Sorar M.

Apathy in incident Parkinson's disease
Khoo T.K., Duncan G., Yarnall A.J., Brooks D.J., Barker R.A., O'Brien J.T., Burn D.J.

APOE and SNCA predict cognitive performance in Parkinson's disease
Mata I., Leverenz J., Trojanowski J., Siderowf A., Ritz B., Rhodes S., Factor S., Wood-Siverio C., Quinn J., Chung K., Espay A., Revilla F., Edwards K., Montine T., Zabetian C.

Apomorphine and levodopa do not rescue parkinsonian ultrasonic vocalization deficits in rats
Doll E.J., Shier J.N., Grant L.M., Ciucci M.R.

Apraxia correlates with fronto-parietal BOLD-signals evoked by dexterous finger movements in Parkinson's disease
Abela E., Bertschi M., Wapp M., Federspiel A., Wiest R., Burgunder J.M., Weder B., Hauf M., Bohlhalter S.

Apraxia of eyelid opening in Parkinson's patient with STN-DBS A novel solution
Chan D.T.M., Lau C.K.Y., Zhu C.X.L., Poon W.S.

Are Cuban ATXN2 large normal alleles prone to expand? Implications for the prenatal testing program
Cruz-Marino T., Laffita-Mesa J.M., Velazquez-Santos M., Aquilera-Rodriguez R., Estupinan-Rodriguez A., Gonzalez-Zaldivar Y., Vazquez-Mojena Y., Velazquez-Perez L.C.

Are patients with psychogenic movement disorders more likely to be healthcare workers?
Perry C., Holmes K., Gruber-Baldini A., Anderson K., Shulman L., Weiner W., Reich S.

Are we measuring postural blood pressure in our movement disorder clinics? A multicentre survey of current practice
Ong T., Davies R., Holden C., Gunawardena I.

Assessing hypersexuality in Parkinson's disease: Validation of a screening questionnaire
de Chazeron I., Pereira B., Llorca P.M., Rieu I., Blanc O., Derost P., Ulla M., Debilly B., Durif F.

Assessing neural oscillatory activity in patients with Parkinson's disease
Brookes M., Stephenson M., Price D., Martin L., Gowland P., Wharton S., Auer D., Blazejewska A., Schwarz S., Bajaj N., Morris P.

Assessing nonmotor symptoms and their influence on the quality of life of Parkinson's disease patients
Muntean M.L., Perju-Dumbrava L.C.

Assessing the benefit and safety of administering intermittent GDNF infusions in PD
Gill S.S., White E., Barua N., Bienemann A., Patel N., Luz M., Barclay L., Mohr E., Mooney L., Coulthard E., Lawrence A., Daniels S., Whone A.L.

Assessing willingness to participate in preventative clinical trials
Killoran A., Biglan K.M., Julian-Baros E., Yoritomo N., Ross C.A.

Assessment of commercial formulations of Mucuna pruriens seeds for levodopa (L-DOPA) content
Soumyanath A., Denne T., Peterson A., Shinto L.

Assessment of motor function by measuring the maximum pinching force in patients with Parkinson's disease
Touge T., Kume K., Ikeda K., Deguchi K., Nakamura Y.

Assessment of progressive supranuclear palsy (PSP) by FDG-PET
Higashi Y., Kamada H., Tabata M.

Assessment of substancia nigra echogenicity in German and Filipino population using a portable ultrasound system
Go C.L., Frenzel A., Rosales R.L., Lee L.V., Benecke R., Dressler D., Walter U.

Assessment of the relationship between total plasma homocysteine and cognitive function in Parkinson's disease
Ojo O.O., Okubadejo N.U., Osinaike O.O., Oladipo O.O., Ojini F.I., Danesi M.A.

Association between CSF biomarkers and clinical phenotype of early Parkinson's disease in the Parkinson's Progression Marker Initiative (PPMI)
Kang J.H., Caspell C., Coffey C., Taylor P., Frasier M., Marek K., Trojanowski J.Q., Shaw L.M.

Association between olfactory dysfunction and cognition in the PPMI study
Siderowf A., Morley J.F., Duda J.E., Weintraub D., For the PPMI Investigators 

Association between olfactory dysfunction and neuropsychiatric manifestations in Parkinson's disease (PD)
Kawashima N., Hasegawa K., Horiuchi E., Yokoyama T., Kumon A., Matsunaga A., Saito M.

Association between the UPDRS and falls and near falls in Parkinson's disease
Parashos S.A., Wielinski C.L., Nance M.A., Erickson-Davis C., Lenarz S.

Association of apolipoprotein E polymorphisms and dopamine replacement therapy complications in Parkinson's disease
Cervantes-Arriaga A., Rodriguez-Violante M., Alonso Vilatela E., Yescas P., Poveda C.

Association of blepharospasm with parkinsonism, and essential tremor
Rana M.A., Rana A.Q.

Association of cumulative some heavy metal exposure with Parkinson's disease
Dashdorj U., Tserensodnom B., Bold B., Chimedregzen U., Komatsu F., Kagawa Y.

Association of rs1182 polymorphism in TOR1A with primary dystonia in Chinese population
Song W., Huang R., Chen K., Chen Y.P., Cao B., Yang Y., Shang H.

Association of the adenosine receptor A2A (ADORA2A) gene with L-dopa induced dyskinesia in Parkinson's disease
Greenbaum L., Cohen O.S., Inzelberg R., Kaplan N., Yahalom G., Kozlova E., Strauss H., Lerer B., Hassin-Baer S.

Association of the Val66Met polymorphism of BDNF with primary dystonia in Chinese population
Chen Y.P., Song W., Huang R., Chen K., Li J.P., Yang Y., Shang H.

Associations between brain microstructural and dopaminergic integrity in Parkinson's disease: A joint diffusion tensor and DAT imaging study
Schuff N., Wu K., Zhang Y., Buckley S., Seibyl J., Marek K.

Associations between the UPDRS postural instability and gait difficulty subscale and measures of balance and falls
Almeida L.R.S., Valenca G., Negreiros N.N., Gruber R.A., Pinto E., Oliveira-Filho J.

Associations of self- reported freezing of gait and timed Up and Go performance with and without dual- tasking
Gruber R.A., Almeida L.R.S., Goldstein Elman J.H., Negreiros N.N., Valenca G.T.

Astasia-abasia and demyelination of corpus callosum
Vittal P., Lea G.

Astroglial activation in the striatum of 6-OHDA-lesioned rats with levodopa-induced dyskinesias
Tomiyama M., Ueno T., Nishijima H., Baba M., Mori F., Wakabayashi K., Yamada J., Ueno S.

Astroglial activation induced by different forms of -synuclein
Fellner L., Schanda K., Reindl M., Poewe W., Wenning G.K., Stefanova N.

Asymmetry of gait in parkinsonian patients and its role in the development of freezing
Frazzitta G., Pezzoli G., Bertotti G., Riboldazzi G., Rovescala R., Maestri R.

Ataxia as a rare presenting symptom in neuromyelitis optica (NMO)
Vatwani R.M.

Ataxia with vitamin E deficiency and Friedreich ataxia with GAA expansion in Moroccan families: Clinical comparison
Imounan F., Benomar A., Bouslam N., Regragui W., Ait Ben Haddou E.H., Bouhouche A., Yahyaoui M.

ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome
Grunewald A., Arns B., Seibler P., Rakovic A., Munchau A., Ramirez A., Sue C.M., Klein C.

Attentional set-shifting deficits correlate with severity of freezing of gait in Parkinson's disease
Moore S.T., Shine J.M., Naismith S.L., Palavra N.C., Dilda V., Morris T.R., Lewis S.J.G.

Attributes related with the MDS-UPDRS Spanish version construct validty
Martinez-Martin P., Alvarez-Sanchez M., Arakaki T., Bergareche-Yarza A., Chade A., Garretto N., Gershanik O., Huang J., Kurtis M.M., Martinez-Castrillo J.C., Mendoza-Rodriguez A., Moore H., Rodriguez-Violante M., Singer C., Stebbins G.T., Tilley B.C., Goetz C.G.

Atypical features in Hashimoto encephalopathy
Pelicao G.R., Prezzi E.D.V., Afonso C.R.A., Vasconcellos L.F.R.

Atypical parkinsonian syndromes and fracture risk Are patients adequately managed?
Yarnall A.J., Duncan G.W., Khoo T.K., Burn D.J.

Atypical parkinsonism in Cerebrotendinous Xanthomatosis (CTX): A family with corticobasal syndrome (CBS)
Rubio Agusti I., Kojovic M., Edwards M.J., Murphy E., Lachmann R., Bhatia K.P.

Automated ambulatory measurement of dyskinesia and bradykinesia
Griffiths R., Kotschet K., Johnson W., Drago J., Evans A., Kempster P., Raghav S., Horne M.K.

Autophagic dysfunction in essential tremor: A postmortem, case-control study
Kuo S.H., Tang G., Ma K., Babij R., Vonsattel J.P.G., Faust P.L., Sulzer D., Louis E.D.

Availability of olfactory bulb and olfactory tract in brain specimens in a brain bank
Silveira-Moriyama L., Kingsbury A., Ayling H., Holton J.L., Sterlacci W., Petrie A., Rajan S., Poewe W., Maier H., Ezquerro M.T.H., Revesz T., Lees A.J.

Axial dystonia as a phenotype of adult onset primary torsion dystonia
Molloy A., Kimmich O., O'Riordan S., Hutchinson M.